Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling
Beth Israel Deaconess Medical Center · Woman's Hospital
Abstract
Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder that occurs upon mutation of either the TSC1 or TSC2 genes, which encode the protein products hamartin and tuberin, respectively. Here, we show that hamartin and tuberin function together to inhibit mammalian target of rapamycin (mTOR)-mediated signaling to eukaryotic initiation factor 4E-binding protein 1 (4E-BP1) and ribosomal protein S6 kinase 1 (S6K1). First, coexpression of hamartin and tuberin repressed phosphorylation of 4E-BP1, resulting in increased association of 4E-BP1 with eIF4E; importantly, a mutant of TSC2 derived from TSC patients was defective in repressing phosphorylation of 4E-BP1. Second, the activity of S6K1 was…
Citation impact
- FWCI
- 23.41
- Percentile
- 100%
- References
- 31
Authors
6- ARAndrew R. Tee
Beth Israel Deaconess Medical Center, Woman's Hospital
- DCDiane C. Fingar
Beth Israel Deaconess Medical Center, Woman's Hospital
- BDBrendan D. Manning
Beth Israel Deaconess Medical Center, Woman's Hospital
- DJDavid J. Kwiatkowski
Beth Israel Deaconess Medical Center, Woman's Hospital
- LCLewis C. Cantley
Beth Israel Deaconess Medical Center, Woman's Hospital
Topics & keywords
- TSC2
- P70-S6 Kinase 1
- TSC1
- Tuberous sclerosis
- PI3K/AKT/mTOR pathway
- RPTOR
- Mechanistic target of rapamycin
- Biology